UK laboratory makes breakthrough in its Covid-19 antibody test development

Offering their support to the Government and NHS to help get the nation tested for coronavirus, a leading health and wellness company has made a breakthrough in its development of a Covid-19 antibody test and is seeking more blood samples to expedite the validation of this test.
Watch more of our videos on Shots! 
and live on Freeview channel 276
Visit Shots! now

YorkTest Laboratories, who has 38 years scientific expertise in the development and provision of home to laboratory finger-prick blood testing services, is using their expertise in IgG testing and existing laboratory facilities to develop a COVID-19 IgG antibody test as a priority for both healthcare staff on the frontline and the general public.

“We already have a laboratory enzyme-linked immunosorbent assay (ELISA) for measuring immunoglobulin G (IgG) reactions to foods. We know that the methods and formulations that we use for this are very robust and scalable, so we already have a great foundation and the expertise in our laboratory for developing the COVID-19 IgG antibody test,” said Dr Gill Hart, Scientific Director at YorkTest Laboratories.

Hide Ad
Hide Ad

“Our core business provision of home-to-laboratory testing is well established with all the equipment, certifications (CE, IVD, ISO), and procedures are already in place to be able to deliver a COVID-19 antibody test solution once development is completed.

YORKTEST LABORATORIES MAKES BREAKTHROUGH IN ITS CORONAVIRUS COVID-19 IgG ANTIBODY TEST DEVELOPMENTYORKTEST LABORATORIES MAKES BREAKTHROUGH IN ITS CORONAVIRUS COVID-19 IgG ANTIBODY TEST DEVELOPMENT
YORKTEST LABORATORIES MAKES BREAKTHROUGH IN ITS CORONAVIRUS COVID-19 IgG ANTIBODY TEST DEVELOPMENT

“Following an appeal to our customer base last week, we have now reached a major milestone as to the feasibility of our COVID-19 IgG antibody test, as we received a number of tested positive for COVID-19 blood samples. Using these samples has enabled us to successfully assess the initial feasibility of our own COVID-19 IgG antibody test.” said Dr Gill.

What YorkTest needs now, however, to expedite the development timeline is many more tested positive COVID-19 blood samples. The company is making an urgent appeal to the general public who have been affected by coronavirus to respond with their help.

“It’s important that our test is accurate and can distinguish between those individuals that definitely have had the virus, and those that haven’t. We need more samples confirmed positive and negative using the swab test for completion of the development.

Hide Ad
Hide Ad

“We also need to demonstrate that the test is reproducible and is able to detect the low levels of antibodies that are present at the start of the infection”. said Dr Gill.

YORKTEST LABORATORIES MAKES BREAKTHROUGH IN ITS CORONAVIRUS COVID-19 IgG ANTIBODY TEST DEVELOPMENTYORKTEST LABORATORIES MAKES BREAKTHROUGH IN ITS CORONAVIRUS COVID-19 IgG ANTIBODY TEST DEVELOPMENT
YORKTEST LABORATORIES MAKES BREAKTHROUGH IN ITS CORONAVIRUS COVID-19 IgG ANTIBODY TEST DEVELOPMENT

YorkTest already has an established home-to-laboratory finger-prick blood collection kit, enabling people to safely and responsibly take a tiny blood sample from the comfort of their own home.

“Once the antibody test has been developed and validated, we could potentially support many individuals, including healthcare workers and businesses with a means to determine whether or not they have been exposed to COVID-19. Our laboratory and team of lab technicians have the capacity to be able to provide over 100,000 COVID-19 antibody tests per week.

“We are also working on an IgM antibody test, which when performed alongside the IgG antibody test, may provide even more information about that person’s phase of recovery from the coronavirus.” added Dr Gill.

Hide Ad
Hide Ad

“YorkTest are keen to collaborate with the Government, NHS England or other private operations that are doing the same; we want to help in the fight against coronavirus.” commented Richard Dawson, Managing Director at YorkTest Laboratories.

To get in touch, and most importantly to provide a positive tested COVID-19 blood sample to help in the fight against coronavirus, please contact YorkTest at [email protected] or call 01904 410 410. For more information, visit yorktest.com/coronavirus

A message from the Editorial Director, Gillian Parkinson:

Thank you for reading this story on our website.

But I also have an urgent plea to make of you.

In order for us to continue to provide high quality local news on this free-to-read site and in print, please purchase a copy of our newspaper as well.

With the coronavirus lockdown having a major impact on our town centres and many of our valued advertisers - and consequently the advertising that we receive - we are more reliant than ever on you buying a copy when you pop out for your essential shop or subscribing for delivery.

Hide Ad
Hide Ad

Our journalists are highly trained by the National Council for the Training of Journalists (NCTJ) and our content is independently regulated by IPSO to some of the most rigorous standards anywhere in the world. Our content is universally trusted - as all independent research proves.

As Baroness Barran said in a House of Lords debate this week on the importance of journalists: "Not only are they a trusted source of facts, but they will have a role to play in rallying communities and getting the message across about how we can keep ourselves and our families safe, and protect our NHS. Undoubtedly, they have a critical role."

But being your eyes and ears comes at a price. So we need your support more than ever to buy our newspapers during this crisis. In return we will continue to forensically cover the local news - not only the impact of the virus but all the positive and uplifting news happening in these dark days.

We thank all our readers and advertisers for their understanding and support - and we wish YOU all the best in the coming weeks. Keep safe, and follow the Government advice. Thank you.

HOW TO SUBSCRIBE:

You can subscribe for delivery by contacting us at [email protected] or calling us on 0330 4033004 for details of a participating newsagent near you.

Related topics: